We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
AUM
$245M
AUM Growth
-$26.3M
Cap. Flow
-$19.2M
Cap. Flow %
-7.82%
Top 10 Hldgs %
63.13%
Holding
62
New
10
Increased
13
Reduced
23
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 47.43%
2 Healthcare 44.85%
3 Industrials 3.37%
4 Consumer Staples 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
1
Microchip Technology
MCHP
$39.3B
$22.4M 9.14%
+250,000
New +$19.7M
SCPH
2
DELISTED
scPharmaceuticals
SCPH
$20.9M 8.53%
2,051,805
-23,992
-1% -$250K
ANIP icon
3
ANI Pharmaceuticals
ANIP
$1.85B
$18.9M 7.7%
350,325
+2,219
+0.6% +$98.4K
INDI icon
4
indie Semiconductor
INDI
$651M
$18.8M 7.67%
2,000,000
-425,000
-18% -$3.84M
TELA icon
5
TELA Bio
TELA
$30.2M
$16.8M 6.85%
1,657,945
+4,326
+0.3% +$44.2K
AVNW icon
6
Aviat Networks
AVNW
$253M
$16.7M 6.82%
500,723
-32,195
-6% -$1.02M
TGAN
7
DELISTED
Transphorm, Inc. Common Stock
TGAN
$15M 6.12%
4,412,593
+803,247
+22% +$2.9M
GSIT icon
8
GSI Technology
GSIT
$203M
$11.1M 4.51%
+2,000,000
New +$8.68M
MRAM icon
9
Everspin Technologies
MRAM
$310M
$7.81M 3.19%
848,430
-1,500
-0.2% -$11.3K
APYX icon
10
Apyx Medical
APYX
$158M
$6.37M 2.6%
1,266,799
+742,798
+142% +$3.76M
BDSX icon
11
Biodesix
BDSX
$216M
$6.23M 2.54%
253,071
-24,156
-9% -$724K
ANVS icon
12
Annovis Bio
ANVS
$73.2M
$5.99M 2.44%
+419,070
New +$5.93M
BKTI icon
13
BK Technologies
BKTI
$294M
$5.48M 2.24%
330,896
-7,049
-2% -$98.9K
CLNN icon
14
Clene
CLNN
$61.7M
$5.22M 2.13%
+296,875
New +$5.8M
LPTH icon
15
Lightpath Technologies
LPTH
$594M
$4.58M 1.87%
3,388,932
-13,000
-0.4% -$18.1K
CMBM
16
DELISTED
Cambium Networks
CMBM
$4.52M 1.84%
296,668
-234,426
-44% -$3.64M
AIRG icon
17
Airgain
AIRG
$71.9M
$3.9M 1.59%
722,534
-2,950
-0.4% -$16.5K
BWEN icon
18
Broadwind
BWEN
$87.3M
$3.79M 1.55%
991,700
-8,300
-0.8% -$34.7K
CGTX icon
19
Cognition Therapeutics
CGTX
$79.5M
$3.73M 1.52%
2,038,853
+1,000
+0% +$2.12K
KPTI icon
20
Karyopharm Therapeutics
KPTI
$157M
$3.17M 1.3%
+118,232
New +$5.09M
FENC icon
21
Fennec Pharmaceuticals
FENC
$341M
$3.09M 1.26%
349,457
+187,303
+116% +$1.56M
BWAY
22
Brainsway
BWAY
$583M
$2.9M 1.18%
+2,543,520
New +$2.28M
THER
23
DELISTED
THERATECHNOLOGIES INC COM
THER
$2.87M 1.17%
3,404,710
-3,724
-0.1% -$3.14K
ABEO icon
24
Abeona Therapeutics
ABEO
$345M
$2.58M 1.05%
638,974
-13,200
-2% -$46.2K
CVV icon
25
CVD Equipment Corp
CVV
$44.1M
$2.47M 1.01%
335,508
+1,600
+0.5% +$14.3K

Similar funds

AIGH Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, AIGH Capital Management held 62 positions worth $245M, down 9.7% from $271M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

AIGH Capital Management withdrew a net $19.2M in Q2 2023, closing 14 positions and reducing 23 holdings. Its most notable exit was Adtran, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIGH Capital Management opened a new position in Microchip Technology worth $22.4M.

  • AIGH Capital Management's largest Q2 2023 buy was Microchip Technology: 250,000 shares worth $22.4M.
  • AIGH Capital Management added most to Apyx Medical in Q2 2023, an estimated $3.76M increase.
  • AIGH Capital Management's biggest Q2 2023 reduction was Digital Turbine, cutting an estimated $5.49M.
  • AIGH Capital Management fully exited Adtran in Q2 2023, selling an estimated $17.1M.
  • AIGH Capital Management's ten largest holdings make up 63% of its $245M portfolio in Q2 2023.
  • AIGH Capital Management opened 10 new positions and closed 14 in Q2 2023.
  • AIGH Capital Management's portfolio value fell 9.7% quarter-over-quarter to $245M.

Based on AIGH Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.